Today I’m talking with Harry Rowland, co-founder and CEO of Endotronix. Endotronix was founded in 2007 and is developing an implantable pressure sensor that can be placed in the pulmonary artery outside the heart.
Dr. Rowland has led the company’s innovation, strategy and technology developments since the project began and has raised millions of dollars in funding. In this episode, he shares the exciting new prospects this technology offers as part of a complete health system that provides tools and feedbacks to help extend and improve patient’s lives.
Dr. Rowland’s background in engineering and healthcare entrepreneurshipAdvanced heart failure, current standards of care and healthcare costsEndotronix implantable sensors and proactive heart disease managementRaising capital for the businessPerseverance and commitment as a startupFuture of Endotronix and clinical testingAdvice for new healthcare startupsEngaging both patients and clinicians to make the product successfulMedical device development in a global market
Learn more about your ad choices. Visit megaphone.fm/adchoices
Connect with listeners
Podcasters use the RadioPublic listener relationship platform to build lasting connections with fansYes, let's begin connecting
Find new listeners
Understand your audience
Engage your fanbase